277 related articles for article (PubMed ID: 27646951)
1. Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012.
Pang HH; Wang X; Stinchcombe TE; Wong ML; Cheng P; Ganti AK; Sargent DJ; Zhang Y; Hu C; Mandrekar SJ; Redman MW; Manola JB; Schilsky RL; Cohen HJ; Bradley JD; Adjei AA; Gandara D; Ramalingam SS; Vokes EE
J Clin Oncol; 2016 Nov; 34(33):3992-3999. PubMed ID: 27646951
[TBL] [Abstract][Full Text] [Related]
2. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
Murthy VH; Krumholz HM; Gross CP
JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
[TBL] [Abstract][Full Text] [Related]
3. Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer.
Hardy D; Liu CC; Xia R; Cormier JN; Chan W; White A; Burau K; Du XL
Cancer; 2009 May; 115(10):2199-211. PubMed ID: 19365824
[TBL] [Abstract][Full Text] [Related]
4. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.
Stewart JH; Bertoni AG; Staten JL; Levine EA; Gross CP
Ann Surg Oncol; 2007 Dec; 14(12):3328-34. PubMed ID: 17682824
[TBL] [Abstract][Full Text] [Related]
5. Racial-Ethnic Disparities in End-of-Life Care Quality among Lung Cancer Patients: A SEER-Medicare-Based Study.
Karanth S; Rajan SS; Sharma G; Yamal JM; Morgan RO
J Thorac Oncol; 2018 Aug; 13(8):1083-1093. PubMed ID: 29753578
[TBL] [Abstract][Full Text] [Related]
6. Participation of the elderly, women, and minorities in pivotal trials supporting 2011-2013 U.S. Food and Drug Administration approvals.
Downing NS; Shah ND; Neiman JH; Aminawung JA; Krumholz HM; Ross JS
Trials; 2016 Apr; 17():199. PubMed ID: 27079511
[TBL] [Abstract][Full Text] [Related]
7. Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials.
Javier-DesLoges J; Nelson TJ; Murphy JD; McKay RR; Pan E; Parsons JK; Kane CJ; Kader AK; Derweesh IH; Nodora J; Patel SP; Martinez ME; Rose BS
Cancer; 2022 Feb; 128(4):770-777. PubMed ID: 34806168
[TBL] [Abstract][Full Text] [Related]
8. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration.
Talarico L; Chen G; Pazdur R
J Clin Oncol; 2004 Nov; 22(22):4626-31. PubMed ID: 15542812
[TBL] [Abstract][Full Text] [Related]
9. Racial disparities in length of stay in hospice care by tumor stage in a large elderly cohort with non-small cell lung cancer.
Hardy D; Chan W; Liu CC; Cormier JN; Xia R; Bruera E; Du XL
Palliat Med; 2012 Jan; 26(1):61-71. PubMed ID: 21606129
[TBL] [Abstract][Full Text] [Related]
10. Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic Review.
Tahhan AS; Vaduganathan M; Greene SJ; Alrohaibani A; Raad M; Gafeer M; Mehran R; Fonarow GC; Douglas PS; Bhatt DL; Butler J
JAMA Cardiol; 2020 Jun; 5(6):714-722. PubMed ID: 32211813
[TBL] [Abstract][Full Text] [Related]
11. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
[TBL] [Abstract][Full Text] [Related]
12. Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: a current view and opportunities for improvement.
Hawk ET; Habermann EB; Ford JG; Wenzel JA; Brahmer JR; Chen MS; Jones LA; Hurd TC; Rogers LM; Nguyen LH; Ahluwalia JS; Fouad M; Vickers SM
Cancer; 2014 Apr; 120 Suppl 7(0 7):1113-21. PubMed ID: 24643649
[TBL] [Abstract][Full Text] [Related]
13. Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013.
Wissing MD; Kluetz PG; Ning YM; Bull J; Merenda C; Murgo AJ; Pazdur R
Cancer; 2014 Oct; 120(19):3025-32. PubMed ID: 24965506
[TBL] [Abstract][Full Text] [Related]
14. Disparities in US Lung Cancer Clinical Trial Enrollment.
Kilic S; Zhao J; Okut H; Jani CT; Radwan A; Dudipala H; Burns L; Tapan U
J Racial Ethn Health Disparities; 2023 Aug; ():. PubMed ID: 37651069
[TBL] [Abstract][Full Text] [Related]
15. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
16. Predictors of enrollment in lung cancer clinical trials.
Du W; Gadgeel SM; Simon MS
Cancer; 2006 Jan; 106(2):420-5. PubMed ID: 16342295
[TBL] [Abstract][Full Text] [Related]
17. Disparities in Representation of Women, Older Adults, and Racial/Ethnic Minorities in Immune Checkpoint Inhibitor Trials.
Riaz IB; Islam M; Khan AM; Naqvi SAA; Siddiqi R; Khakwani KZR; Asghar N; Ikram W; Hussain SA; Singh P; Warner JL; Sonpavde GP; Odedina FT; Kehl KL; Duma N; Bryce AH
Am J Med; 2022 Aug; 135(8):984-992.e6. PubMed ID: 35483426
[TBL] [Abstract][Full Text] [Related]
18. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.
Tannenbaum SL; Koru-Sengul T; Zhao W; Miao F; Byrne MM
Cancer J; 2014; 20(4):237-45. PubMed ID: 25098282
[TBL] [Abstract][Full Text] [Related]
19. Minority participation in Gynecologic Oncology Group (GOG) Studies.
Scalici J; Finan MA; Black J; Harmon MD; Nicolson W; Lankes HA; Brady WE; Rocconi RP
Gynecol Oncol; 2015 Aug; 138(2):441-4. PubMed ID: 26013697
[TBL] [Abstract][Full Text] [Related]
20. Trends in participant race and sex reporting in lung cancer phase III clinical trials.
Aslam FN; Manochakian R; Lou Y; Colon-Otero G; Sher T
Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1856. PubMed ID: 37421166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
